수술 후 회복용 단백질 가수분해물 시장 : 기회, 성장 요인, 업계 동향 분석 및 예측(2025-2034년)

The Global Post-Surgical Recovery Protein Hydrolysates Market was valued at USD 2.3 billion in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 5 billion by 2034.

The market growth is driven by multiple factors, including demographic aging, rising surgical volumes, and evolving evidence-based clinical nutrition practices. Technological advancements in protein hydrolysate formulations are improving digestibility, efficacy, and patient compliance, while expanding accessibility in emerging markets with developing surgical nutrition infrastructure. Hospitals and institutional channels continue to dominate the market due to concentrated usage during the perioperative period and strong influence from clinical protocols and hospital formularies. Retail and home healthcare channels contribute the remaining market revenue, serving patients in post-discharge recovery phases. The trend toward optimized perioperative nutrition, combined with broader adoption of protein hydrolysates in surgical care pathways, positions this market for sustained expansion over the next decade.

The whey protein hydrolysate segment held a 43.8% share in 2024 and is expected to grow at a CAGR of 7.7% through 2034. Recognized for its superior amino acid profile, particularly leucine, whey hydrolysate is ideal for stimulating muscle protein synthesis and supporting rapid recovery. Its quick absorption ensures peak plasma amino acid levels within 30-60 minutes, making it highly suitable for post-surgical patients with compromised digestion.

The hospital segment accounted for a 51.8% share in 2024 and is projected to grow at a CAGR of 7.7% through 2034. Hospitals remain the primary consumption point for protein hydrolysates during the preoperative and postoperative periods. Usage is guided by clinical protocols, formulary decisions, and quality metrics that emphasize reducing complications and shortening patient stays.

North America Post-Surgical Recovery Protein Hydrolysates Market held 33.2% share in 2024, with a projected CAGR of 7.7% through 2034. The region's dominance is supported by a high volume of surgeries among an aging population, widespread adoption of clinical nutrition guidelines such as ERAS protocols in over 60% of major hospitals, favorable reimbursement policies for enteral nutrition through Medicare and private insurance, and strong distribution networks from major players like Abbott Nutrition and Nestle Health Science.

Major players operating in the Post-Surgical Recovery Protein Hydrolysates Market include Abbott Nutrition, Nestle Health Science, Fresenius Kabi, Ajinomoto Co., Baxter International, B. Braun Melsungen, Danone Nutricia, Kate Farms, Laboratorios Ordesa, Mead Johnson Nutrition, Medline Industries, Meiji Holdings, Nutricia Advanced Medical Nutrition, Otsuka Pharmaceutical, Real Food Blends, Solace Nutrition, Targeted Medical Pharma, Victus, Cambrooke Therapeutics, and Vitaflo International. Key strategies adopted by companies in the Post-Surgical Recovery Protein Hydrolysates Market include developing innovative protein formulations that enhance absorption and bioavailability, investing in R&D to improve efficacy and patient compliance, expanding into emerging markets with growing surgical infrastructure, and strengthening partnerships with hospitals and clinical nutrition departments. Firms focus on building robust distribution networks, securing formulary placements, and offering tailored perioperative nutrition solutions.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Source
  • 2.2.3 Formulation type
  • 2.2.4 Surgery type
  • 2.2.5 End use
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier Landscape
  • 3.1.2 Profit Margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By formulation type
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries ( Note: the trade statistics will be provided for key countries only)
• 3.12 Sustainability and Environmental Aspects
  • 3.12.1 Sustainable Practices
  • 3.12.2 Waste Reduction Strategies
  • 3.12.3 Energy Efficiency in Production
  • 3.12.4 Eco-friendly Initiatives
• 3.13 Carbon Footprint Considerations

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2034 (USD Million) (Tons)

• 5.1 Key trends
• 5.2 Whey Protein Hydrolysate
• 5.3 Casein Hydrolysate
• 5.4 Collagen Hydrolysate
• 5.5 Poultry Protein Hydrolysate
• 5.6 Plant-Based Protein Hydrolysates

Chapter 6 Market Estimates and Forecast, By Formulation Type, 2021 - 2034 (USD Million) (Tons)

• 6.1 Key trends
• 6.2 Standard Peptide-Based Formulations
• 6.3 Immunonutrition Formulations
• 6.4 High Protein/Low Carbohydrate Formulations
• 6.5 Glutamine-Enriched Formulations
• 6.6 MCT-Enhanced Formulations
• 6.7 Wound Healing Specific Formulations

Chapter 7 Market Estimates and Forecast, By Surgery Type, 2021 - 2034 (USD Million) (Tons)

• 7.1 Key trends
• 7.2 Gastrointestinal Surgery
  • 7.2.1 Colorectal Surgery
  • 7.2.2 Bariatric Surgery
  • 7.2.3 Hepatobiliary Surgery
  • 7.2.4 Pancreatic Surgery
  • 7.2.5 Upper GI Surgery
• 7.3 Oncologic Surgery
  • 7.3.1 Head and Neck Cancer Surgery
  • 7.3.2 Esophageal and Gastric Cancer Surgery
  • 7.3.3 Gynecologic Oncology Surgery
  • 7.3.4 Bladder Cancer Surgery
  • 7.3.5 Colorectal Cancer Surgery
• 7.4 Orthopedic Surgery
  • 7.4.1 Joint Replacement Surgery (Knee, Hip)
  • 7.4.2 Spinal Surgery
  • 7.4.3 Trauma Reconstruction Surgery
• 7.5 Cardiac Surgery
  • 7.5.1 Coronary Artery Bypass Grafting (CABG)
  • 7.5.2 Valve Replacement Surgery
  • 7.5.3 Heart Transplant Surgery
• 7.6 Trauma & Burns
  • 7.6.1 Blunt or Penetrating Trauma
  • 7.6.2 Polytrauma
  • 7.6.3 Partial Thickness Burns
  • 7.6.4 Full Thickness Burns
  • 7.6.5 High TBSA Burns
• 7.7 General & Mixed Surgery
  • 7.7.1 Hernia Repair
  • 7.7.2 Appendectomy
  • 7.7.3 Cholecystectomy
  • 7.7.4 Exploratory Laparotomy

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 (USD Million) (Tons)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Home Healthcare
• 8.4 Long-Term Care Facilities
• 8.5 Ambulatory Surgical Centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Million) (Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbott Nutrition
• 10.2 Ajinomoto Co.
• 10.3 B. Braun Melsungen
• 10.4 Baxter International
• 10.5 Cambrooke Therapeutics
• 10.6 Danone Nutricia
• 10.7 Fresenius Kabi
• 10.8 Kate Farms
• 10.9 Laboratorios Ordesa
• 10.10 Mead Johnson Nutrition
• 10.11 Medline Industries
• 10.12 Meiji Holdings
• 10.13 Nestle Health Science
• 10.14 Nutricia Advanced Medical Nutrition
• 10.15 Otsuka Pharmaceutical
• 10.16 Real Food Blends
• 10.17 Solace Nutrition
• 10.18 Targeted Medical Pharma
• 10.19 Victus
• 10.20 Vitaflo International
• 10.21 Others